Clinical Trial Update: Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism [Phase 2]

View source ↗

Summary

Phase II long-term randomized trial evaluating recombinant human insulin-like growth factor I in children with hyperinsulinism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinism

Drugs mentioned

• Recombinant human insulin-like growth factor I (insulin-like growth factor I)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Hyperinsulinism | Phase 2 | Status: COMPLETED